The companies that enable drug discovery, development, and commercialization — CROs, CDMOs, lab services, and life-science tools and software — are among the most sought-after assets in the market. Buyers prize scientific differentiation, blue-chip customer relationships, and recurring, regulated revenue.
Objective’s life-science bankers understand the science and the buyers. We position these businesses to global strategics and specialized sponsors, and we run a focused process that rewards technical depth and customer concentration done right.
